Press Release Archive

01.16.2012

Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer’s Disease

01.10.2012

Ventana to collaborate with Pfizer and CST on companion diagnostic to identify lung cancer patients with ALK gene rearrangements

01.09.2012

Introducing nutritionpossible.com – A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health

01.09.2012

SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma

01.05.2012

PFIZER INITIATES PHASE 1 CLINICAL TRIAL FOR FVIIa HEMOPHILIA DRUG CANDIDATE DEVELOPED BY CATALYST BIOSCIENCES

01.02.2012

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

12.30.2011

Pfizer Receives FDA Approval to Extend Use of Prevnar 13® for Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older

12.25.2011

CollPlant to develop orthopedic product with Pfizer

12.24.2011

Karo Bio AB announced that it has entered into a research collaboration agreement with Pfizer to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.

12.21.2011

Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms

12.20.2011

Antares Pharma Enters Licensing Agreement With Pfizer Consumer Healthcare

12.19.2011

Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts